Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

GADD45gamma: a new vitamin D-regulated gene that is antiproliferative in prostate cancer cells.

Flores O, Burnstein KL.

Endocrinology. 2010 Oct;151(10):4654-64. doi: 10.1210/en.2010-0434. Epub 2010 Aug 25.

2.

Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.

Krishnan AV, Shinghal R, Raghavachari N, Brooks JD, Peehl DM, Feldman D.

Prostate. 2004 May 15;59(3):243-51.

PMID:
15042599
3.

CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.

Ikezoe T, Gery S, Yin D, O'Kelly J, Binderup L, Lemp N, Taguchi H, Koeffler HP.

Cancer Res. 2005 Jun 1;65(11):4762-8.

4.

1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.

Zhao XY, Peehl DM, Navone NM, Feldman D.

Endocrinology. 2000 Jul;141(7):2548-56.

PMID:
10875257
5.

Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.

Akutsu N, Lin R, Bastien Y, Bestawros A, Enepekides DJ, Black MJ, White JH.

Mol Endocrinol. 2001 Jul;15(7):1127-39.

PMID:
11435613
6.
7.
8.

Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer.

Yang ES, Maiorino CA, Roos BA, Knight SR, Burnstein KL.

Mol Cell Endocrinol. 2002 Jan 15;186(1):69-79.

PMID:
11850123
9.

Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.

Murthy S, Agoulnik IU, Weigel NL.

Prostate. 2005 Sep 1;64(4):362-72.

PMID:
15754350
10.

25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.

Barreto AM, Schwartz GG, Woodruff R, Cramer SD.

Cancer Epidemiol Biomarkers Prev. 2000 Mar;9(3):265-70.

11.

20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.

Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.

Anticancer Res. 1999 May-Jun;19(3A):1689-97.

PMID:
10470102
12.

Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells.

Wang WL, Chatterjee N, Chittur SV, Welsh J, Tenniswood MP.

Mol Cancer. 2011 May 18;10:58. doi: 10.1186/1476-4598-10-58.

13.

1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells.

Rohan JN, Weigel NL.

Endocrinology. 2009 May;150(5):2046-54. doi: 10.1210/en.2008-1395. Epub 2009 Jan 22.

14.

Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.

Skowronski RJ, Peehl DM, Feldman D.

Endocrinology. 1995 Jan;136(1):20-6.

PMID:
7530193
15.

L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells.

Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL, Juang HH.

Am J Physiol Cell Physiol. 2012 Feb 15;302(4):C676-85. doi: 10.1152/ajpcell.00180.2011. Epub 2011 Nov 23.

16.

Gadd45gamma is androgen-responsive and growth-inhibitory in prostate cancer cells.

Jiang F, Wang Z.

Mol Cell Endocrinol. 2004 Jan 15;213(2):121-9.

PMID:
15062559
17.

The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.

Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.

Clin Cancer Res. 2000 Mar;6(3):901-8.

18.

1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.

Zhao XY, Ly LH, Peehl DM, Feldman D.

Endocrinology. 1997 Aug;138(8):3290-8.

PMID:
9231780
19.

Antiproliferative signalling by 1,25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation.

Banwell CM, Singh R, Stewart PM, Uskokovic MR, Campbell MJ.

Recent Results Cancer Res. 2003;164:83-98.

PMID:
12899515
Items per page

Supplemental Content

Write to the Help Desk